IMS Health (RX) Shares Down 25% On Raw Earnings
October 18, 2007 by Douglas A. McIntyreBrutal, IMS (RX) shares are selling off 25% to $21.80, a 52-week low
Bad earnings followed by downgrades.
IMS Health which is a provider of market intelligence to the pharmaceutical and healthcare industries, announced third-quarter 2007 revenue of $538.8 million, up 12 percent or 8 percent on a constant-dollar basis, compared with revenue of $482.7 million for the third quarter of 2006.
Operating income in the third quarter of 2007 was $117.1 million, up 1 percent on both a reported and constant-dollar basis, compared with $115.4 million in the year-earlier period.
Third-quarter profit fell 18 percent as earnings were hit by a change in the German tax rate.
Robert W. Baird promptly downgraded the shares.
Douglas A. McIntyre
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.